CEO, Founder

Chris Watson is a highly esteemed researcher in the field of cardiovascular disease, diabetes and global health and a Reader at Queen’s University Belfast. He has over 120 peer reviewed publications, has filed 5 patents and has secured grants totalling over £11M in research funding. Dr. Watson pioneered the discovery of 5-aza as a potential treatment option for cardiac disease.